Zaffaroni N - Search Results

1

The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines.

De Santi M, Galluzzi L, Lucarini S, Paoletti MF, Fraternale A, Duranti A, De Marco C, Fanelli M, Zaffaroni N, Brandi G, Magnani M. De Santi M, et al. Among authors: zaffaroni n. Breast Cancer Res. 2011 Mar 24;13(2):R33. doi: 10.1186/bcr2855. Breast Cancer Res. 2011. PMID: 21435243 Free PMC article.

2

Activity of a chartreusin analog, elsamicin A, on breast cancer cells.

Silvestrini R, Sanfilippo O, Zaffaroni N, De Marco C, Catania S. Silvestrini R, et al. Among authors: zaffaroni n. Anticancer Drugs. 1992 Dec;3(6):677-81. doi: 10.1097/00001813-199212000-00018. Anticancer Drugs. 1992. PMID: 1288737

3

Fludarabine as a modulator of cisplatin activity in human tumour primary cultures and established cell lines.

Zaffaroni N, Orlandi L, Gornati D, De Marco C, Vaglini M, Silvestrini R. Zaffaroni N, et al. Eur J Cancer. 1996 Sep;32A(10):1766-73. doi: 10.1016/0959-8049(96)00176-1. Eur J Cancer. 1996. PMID: 8983288

4

Modulation by lonidamine on the combined activity of cisplatin and epidoxorubicin in human breast cancer cells.

Silvestrini R, Gornati D, Zaffaroni N, Bearzatto A, De Marco C. Silvestrini R, et al. Among authors: zaffaroni n. Breast Cancer Res Treat. 1997 Jan;42(2):103-12. doi: 10.1023/a:1005725203159. Breast Cancer Res Treat. 1997. PMID: 9138599

5

Lonidamine as a modulator of taxol activity in human ovarian cancer cells: effects on cell cycle and induction of apoptosis.

Orlandi L, Zaffaroni N, Bearzatto A, Villa R, De Marco C, Silvestrini R. Orlandi L, et al. Among authors: zaffaroni n. Int J Cancer. 1998 Oct 29;78(3):377-84. doi: 10.1002/(SICI)1097-0215(19981029)78:3<377::AID-IJC20>3.0.CO;2-2. Int J Cancer. 1998. PMID: 9766575

6

Involvement of bcl-2 and p21waf1 proteins in response of human breast cancer cell clones to Tomudex.

Orlandi L, Bearzatto A, Abolafio G, De Marco C, Daidone MG, Zaffaroni N. Orlandi L, et al. Among authors: zaffaroni n. Br J Cancer. 1999 Sep;81(2):252-60. doi: 10.1038/sj.bjc.6690685. Br J Cancer. 1999. PMID: 10496350 Free PMC article.

7

Lack of p21waf1 and p27kip1 protein induction by interferon-alpha2a in human melanoma cell lines.

Bearzatto A, Orlandi L, De Marco C, Daidone MG, Zaffaroni N. Bearzatto A, et al. Among authors: zaffaroni n. Melanoma Res. 1999 Oct;9(5):457-63. doi: 10.1097/00008390-199910000-00005. Melanoma Res. 1999. PMID: 10596912

8

Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agents.

Folini M, De Marco C, Orlandi L, Daidone MG, Zaffaroni N. Folini M, et al. Among authors: zaffaroni n. Eur J Cancer. 2000 Oct;36(16):2137-45. doi: 10.1016/s0959-8049(00)00295-1. Eur J Cancer. 2000. PMID: 11044653

9

Cell growth inhibition, G2M cell cycle arrest and apoptosis induced by the imidazoacridinone C1311 in human tumour cell lines.

Zaffaroni N, De Marco C, Villa R, Riboldi S, Daidone MG, Double JA. Zaffaroni N, et al. Eur J Cancer. 2001 Oct;37(15):1953-62. doi: 10.1016/s0959-8049(01)00227-1. Eur J Cancer. 2001. PMID: 11576853

10

A new indole-3-carbinol tetrameric derivative inhibits cyclin-dependent kinase 6 expression, and induces G1 cell cycle arrest in both estrogen-dependent and estrogen-independent breast cancer cell lines.

Brandi G, Paiardini M, Cervasi B, Fiorucci C, Filippone P, De Marco C, Zaffaroni N, Magnani M. Brandi G, et al. Among authors: zaffaroni n. Cancer Res. 2003 Jul 15;63(14):4028-36. Cancer Res. 2003. PMID: 12874002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters